Continue to site >
Trending ETFs

BRISTOL-MYERS SQUIBB COMPANY

Stock (NYSE)
BMY
Payout Change
Pending
Price as of:
$57.96 +0.08 +0%
Dividend (Fwd)
$2.40
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
4.14%
BMY: NYSE (Stock)

BRISTOL-MYERS SQUIBB COMPANY

Payout Change
Pending
Price as of:
$57.96 +0.08 +0%
Dividend (Fwd)
$2.40
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
4.14%
BMY: NYSE (Stock)

BRISTOL-MYERS SQUIBB COMPANY

$57.96 +0%
Dividend (Fwd)
$2.40
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
4.14%
Payout Change
Pending
Analysis

Name

As of 11/21/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$57.96

0.14%

$118 B

4.14%

$2.40

-

Dividend Data
Stock Data
Avg Price Recovery
13.8 Days
Best dividend capture stocks in Nov
Payout Ratio (FWD)
Fwd Payout Ratio is used to examine if a company’s earnings can support the current dividend payment amount. It divides the Forward Annualized Dividend by FY1 EPS. Click here to learn more.
34.00%
Years of Dividend Increase
Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases.
16 yrs
Dividend Frequency
Quarterly
Health Care Avg Yield
1.58%
5 best health care dividend stocks
Market Cap
$118.101 B
Day’s Range
$57.47 - $58.22
Volume
1,995,988
52 Wk Low/High
$39.35 - $61.08
Percent off 52 Wk High
-5.11%
FY1 PE
8.21x
FY1 EPS / Growth
$7.06 / 691.78%

Name

As of 11/21/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$57.96

0.14%

$118 B

4.14%

$2.40

-

Ratings - BMY

Dividend Safety

A+

16 years of consecutive dividend increase.

Yield Attractiveness

A

4.12% forward dividend yield. Top 30%.

Returns Risk

A+

0.4 beta (5Y monthly). Diversifier.

Returns Potential

A+

18% dividend CAGR last 3 years. Top 20%.

Quant Recommendation - BMY

Maximize Income Goal

Target

Yields of 7-9%

Horizon

Short

Risk

Moderate-to-high

Retirement Income Goal

Target

Blend low volatility & yield

Horizon

Long

Risk

Low

Monthly Income Goal

Regular payouts for BMY are paid quarterly. Recommendation not provided. See Best Monthly Dividend Stocks Model Portfolio for our top monthly income ideas.

Growth Goal

Target

Market-beating returns

Horizon

Long

Risk

Moderate

Income & Growth Goal

Target

Blend yield & returns

Horizon

Moderate

Risk

Moderate

Sector Income & Growth Goal

Target

Blend yield & returns in the Health Care sector

Horizon

Long

Risk

Moderate-to-high

BMY Payout History (Paid, Declared and Estimated)

Declared
Paid
Estimated
Year Calendar Year Payout (USD) Calendar Year Payout Growth (USD) Pay Date Declared Date Ex-dividend Date Payout Amount (USD) Qualified Dividend? Payout Type Frequency Days Taken For Stock Price To Recover Yield on Cost
2026e - -
2026-10-30
2026-09-18 2026-10-05 $0.6000 Qualified Regular Quarterly - -
2026-07-31
2026-06-12 2026-07-06 $0.6000 Qualified Regular Quarterly - -
2026-05-01
2026-03-03 2026-04-06 $0.6000 Qualified Regular Quarterly - -
2026-01-30
2025-12-08 2026-01-05 $0.6000 Qualified Regular Quarterly - -
2025e - -
2025-10-31
2025-09-19 2025-10-03 $0.6000 Qualified Regular Quarterly - -
2025-08-01
2025-06-13 2025-07-04 $0.6000 Qualified Regular Quarterly - -
2025-05-01
2025-03-03 2025-04-04 $0.6000 Qualified Regular Quarterly - -
2025-01-31
2024-12-06 2025-01-03 $0.6000 Qualified Regular Quarterly - -
2024e - -
2024-11-01
2024-09-10 2024-10-04 $0.6000 Qualified Regular Quarterly - 1.11%
2024-08-01
2024-06-18 2024-07-05 $0.6000 Qualified Regular Quarterly - 1.51%
2024-05-01
2024-03-01 2024-04-04 $0.6000 Qualified Regular Quarterly - 1.17%
2024-02-01
2023-12-06 2024-01-04 $0.6000 Qualified Regular Quarterly - 1.15%

BMY Dividend Growth CAGR

Dividend Capture Strategy for BMY

Dividend capture strategy is based on BMY’s historical data. Past performance is no guarantee of future results.

Step 1: Buy BMY shares 1 day before the ex-dividend date

Purchase Date

Jan 02, 2025

Upcoming Ex-Dividend Date

Jan 03, 2025

Step 2: SEll BMY shares when price recovers

Sell Date (Estimate)

Jan 17, 2025

Avg Price Recovery

13.8 Days

Avg yield on cost

0.90%

See Full History

News & Research

News

Research

Sorry, there are no articles available for this stock.

Company Profile

Company Overview

Exchanges: NYSE

Sector: Health Care

Industry: Biotech Pharma

No company description available.

Related Companies

Company Name

Price

Change

% Change

Daiichi Sankyo Co., Ltd.

$30.19

$2.30

8.247%

Dogwood Therapeutics, Inc.

$2.37

-$0.06

-2.469%

Dyne Therapeutics, Inc.

$29.87

-$0.12

-0.400%

DURECT CORP

$0.86

-$0.04

-4.444%

Dermata Therapeutics, Inc.

$1.22

$0.06

5.172%

Fuse Science Inc

$0.01

$0.01

-100.000%

Bright Minds Biosciences Inc

$32.56

-$0.11

-0.337%

DYNAVAX TECHNOLOGIES CORP

$12.26

$0.09

0.740%

Denali Therapeutics Inc.

$23.93

-$0.49

-2.007%

Chemomab Therapeutics Ltd.

$1.60

-$0.04

-2.439%

© 2020&nbsp Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer